The histological spectrum of the central fibrous body (CFB) of the heart, particularly in humans, is not fully characterized. Herein, we describe the presence of cartilage and bone within the CFB of 2 explanted heart specimens from patients with known mutation-driven cardiomyopathy involving the TNNI3 and TNNT2 genes, review the existing literature on the identified variants particularly TNNI3 (p.Asn185Thrfs*14) and TNNT2 (p.Arg141Trp), and provide insights into the plausible nature of such histopathological observation based on animal studies and the few reported cases in humans.
SaremiFSánchez-QuintanaDMoriS, et al.Fibrous skeleton of the heart: anatomic overview and evaluation of pathologic conditions with CT and MR imaging.Radiographics. 2017;
37(5):1330–1351.
2.
ManoleCGMarinescuBGMartaDNicolescuMI.Areas of cartilaginous and osseous metaplasia after experimental myocardial infarction in rats.Anat Rec (Hoboken). 2019;
302(6):947–953.
3.
GopalakrishnanGBlevinsWEVan AlstineWG.Osteocartilaginous metaplasia in the right atrial myocardium of healthy adult sheep. J Vet Diagn Invest. 2007;
19(5):518–524.
4.
JamesTN.Structure and function of the sinus node, AV node and His bundle of the human heart: part I-structure.Prog Cardiovasc Dis. 2002;
45(3):235–567.
5.
BaloghKFerrisJAAherneWA.Fibrocartilage in the heart. Lancet. 1971;
1(7703):802–803.
6.
SteinerIKasparováPKohoutADominikJ.Bone formation in cardiac valves: a histopathological study of 128 cases.Virchows Arch. 2007;
450(6):653–657.
7.
FerrisJAAherneWA.Cartilage in relation to the conducting tissue of the heart in sudden death. Lancet. 1971;
1(7689):64–66.
8.
MatturriLOttavianiGRamosSGRossiL.Sudden Infant Death Syndrome (SIDS): a study of cardiac conduction system. Cardiovasc Pathol. 2000;
9(3):137–145.
9.
MoralesAHershbergerRE.The rationale and timing of molecular genetic testing for dilated cardiomyopathy.Can J Cardiol. 2015;
31(11):1309–1312.
10.
CirinoALHoC. Hypertrophic cardiomyopathy overview. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2020. August 5, 2008. Updated June 6, 2019.
11.
McNallyEMBarefieldDYPuckelwartzMJ.The genetic landscape of cardiomyopathy and its role in heart failure.Cell Metab. 2015;
21(2):174–182.
12.
Marin-GarciaJAkhmedovARybinVMoeGW.Post-Genomic Cardiology. 2nd ed.
Amsterdam, the Netherlands:
Elsevier; 2014:924.
13.
CarballoSRobinsonPOtwayR, et al.Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.Circ Res. 2009;
105(4):375–382.
14.
MogensenJKuboTDuqueM, et al.Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.J Clin Invest. 2003;
111(2):209–216. Erratum in: J Clin Invest. 2003;111(6):925.
15.
MoolmanJCCorfieldVAPosenB, et al.Sudden death due to troponin T mutations.J Am Coll Cardiol. 1997;
29(3):549–555.
16.
PasqualeFSyrrisPKaskiJPMogensenJMcKennaWJElliottP.Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ Cardiovasc Genet. 2012;
5(1):10–17.
17.
MoralesAHershbergerRE.Genetic evaluation of dilated cardiomyopathy.Curr Cardiol Rep. 2013;
15(7):375.
18.
StensonPDMortMBallEVShawKPhillipsACooperDN.The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.Hum Genet. 2014;
133(1):1–9.
19.
MenonSCMichelsVVPellikkaPA, et al.Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology.Clin Genet. 2008;
74(5):445–454.
20.
LiDCzernuszewiczGZGonzalezO, et al.Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy.Circulation. 2001;
104(18):2188–2193.
21.
VillardEDuboscq-BidotLCharronP, et al.Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J. 2005;
26(8):794–803.
22.
MillatGBouvagnetPChevalierP, et al.Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.Eur J Med Genet. 2011;
54(6):e570–e575.
23.
PughTJKellyMAGowrisankarS, et al.The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.Genet Med. 2014;
16(8):601–608.
24.
LongPALarsenBTEvansJMOlsonTM.Exome sequencing identifies pathogenic and modifier mutations in a child with sporadic dilated cardiomyopathy. J Am Heart Assoc. 2015;
4(12):e002443.
25.
WalshRThomsonKLWareJS, et al.Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.Genet Med. 2017;
19(2):192–203.
26.
LuQWMorimotoSHaradaK, et al.Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.J Mol Cell Cardiol. 2003;
35(12):1421–1427.
27.
MirzaMMarstonSWillottR, et al.Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.J Biol Chem. 2005;
280(31):28498–28506.
28.
VenkatramanGGomesAVKerrickWGPotterJD.Characterization of troponin T dilated cardiomyopathy mutations in the fetal troponin isoform.J Biol Chem. 2005;
280(18):17584–17592.
29.
RobinsonPGriffithsPJWatkinsHRedwoodCS.Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.Circ Res. 2007;
101(12):1266–1273.
30.
LiuBTikunovaSBKlineKPSiddiquiJKDavisJP.Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates.PLoS One. 2012;
7(6):e38259.
31.
SommeseRFNagSSuttonSMillerSMSpudichJARuppelKM.Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.PLoS One. 2013;
8(12):e83403.
32.
MemoMLeungMCWardDG, et al.Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca2+ sensitivity. Cardiovasc Res. 2013;
99(1):65–73.
33.
LekMKarczewskiKJMinikelEV, et al.; Exome Aggregation Consortium.
Analysis of protein-coding genetic variation in 60,706 humans.Nature. 2016;
536(7616):285–291.
34.
BienengraeberMOlsonTMSelivanovVA, et al.ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet. 2004;
36(4):382–387.
35.
HuDBarajas-MartínezHTerzicA, et al.ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int J Cardiol. 2014;
171(3):431–442.
36.
van BonBWGilissenCGrangeDK, et al.Cantú syndrome is caused by mutations in ABCC9.Am J Hum Genet. 2012;
90(6):1094–1101.
37.
HarakalovaMvan HarsselJJTerhalPA, et al.Dominant missense mutations in ABCC9 cause Cantú syndrome.Nat Genet. 2012;
44(7):793–796.
38.
BrauchKMKarstMLHerronKJ, et al.Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.J Am Coll Cardiol. 2009;
54(10):930–941.
39.
LiDMoralesAGonzalez-QuintanaJ, et al.Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.Clin Transl Sci. 2010;
3(3):90–97.
40.
RefaatMMLubitzSAMakinoS, et al.Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.Heart Rhythm. 2012;
9(3):390–396.
41.
DuránACLópezDGuerreroAMendozaAArquéJMSans-ComaV.Formation of cartilaginous foci in the central fibrous body of the heart in Syrian hamsters (Mesocricetus auratus).J Anat. 2004;
205(3):219–227.
42.
Garcia-MartinezVSanchez-QuintanaDHurleJM.Histogenesis of the semilunarvalves: an immunohistochemical analysis of tenascin and type-I collagen distribution in developing chick heart valves.Cell Tissue Res. 1990;
259(2):299–304.
43.
DuncanRLTurnerCH.Mechanotransduction and the functional response of bone to mechanical strain.Calcif Tissue Int. 1995;
57(5):344–358.
44.
TurnerCHPavalkoFM.Mechanotransduction and functional response of the skeleton to physical stress: the mechanisms and mechanics of bone adaptation.J Orthop Sci. 1998;
3(6):346–55.
45.
MartinRB.Toward a unifying theory of bone remodeling. Bone. 2000;
26(1):1–6.
46.
WeytsFABosmansBNiesingRvan LeeuwenJPWeinansH.Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation.Calcif Tissue Int. 2003;
72(4):505–512.
47.
LevMWidranJ.The dissection of the atrioventricular node, bundle and bundle branches in the human heart.Circulation. 1951;
4(6):863–867.
48.
AndersonRHHoSYBeckerAE.The surgical anatomy of the conduction tissues.Thorax. 1983;
38(6):408–420.
49.
DonnellyWHHawkinsH.Optimal examination of the normally formed perinatal heart.Human Pathology1987:
18(1):55–60.
50.
YanagawaNNakajimaY.A simple dissection method for the conduction system of the human heart.Anat Sci Educ. 2009;
2(2):78–80.
